Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Liabilities from Discontinued Operations: 2019

Historic Liabilities from Discontinued Operations for Cumberland Pharmaceuticals (CPIX) over the last 1 years, with Dec 2019 value amounting to $2.2 million.

  • Cumberland Pharmaceuticals' Liabilities from Discontinued Operations was N/A to $1.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2019, which is N/A change from last year.
  • According to the latest figures from FY2019, Cumberland Pharmaceuticals' Liabilities from Discontinued Operations is $2.2 million.
  • In the past 5 years, Cumberland Pharmaceuticals' Liabilities from Discontinued Operations registered a high of $2.2 million during FY2019, and its lowest value of $2.2 million during FY2019.
  • For the 1-year period, Cumberland Pharmaceuticals' Liabilities from Discontinued Operations averaged around $2.2 million, with its median value being $2.2 million (2019).